12.24 +0.07 (0.58%)
Pre-market: 8:51AM EST
|Bid||12.25 x 800|
|Ask||12.25 x 5400|
|Day's range||12.10 - 12.58|
|52-week range||10.47 - 13.48|
|PE ratio (TTM)||11.07|
|Earnings date||24 Jan 2018|
|Forward dividend & yield||0.60 (4.58%)|
|1y target est||12.85|
Most all-wheel drive vehicles are made for soft off-roading—gravel roads, snowy passes, the occasional beach—not for the boulder-strewn mountain-goat trails the toughest Jeeps are built to roam. Ford sees that as an opportunity. Its new Ranger pickup, revived after a seven-year hiatus, is aimed at recreational enthusiasts who don’t need a work truck but love the flexibility a pickup offers.
Shares of Ford Motor Co. end at their lowest level since late November after the car maker presented a grim picture of its profit this year and its preliminary 2017 numbers fall short.
Auto makers rolled out a classic Mustang, trays of schnapps and even Arnold Schwarzenegger while unveiling new trucks and SUVs on the road to the era of electric and driverless cars.
Shares were broadly higher in Asia on Thursday after a rally on Wall Street that took the Dow Jones industrial average to its first close above 26,000. Traders are awaiting the release of Chinese GDP figures ...
Stocks had a huge day, sending the major indexes to new records. Shares of Juno Therapeutics soared following a buyout report, and Ford slumped on disappointing guidance.
As part of the broader Smart Columbus initiative, commuter solution Chariot – a subsidiary of Ford Motor Company’s mobility arm – today announced it is expanding its service to Columbus, in partnership with JPMorgan Chase and in support of the city’s transformation to become a model for connected cities of the future.
Ford Motor (F) tumbled to the bottom of the S&P 500 on Wednesday, hurt by its guidance. Ford slipped 92 cents, or 7%, to $12.18, while the S&P 500 climbed 26.14 points, or 0.94%, to 2802.56. Ford said ...
Stocks that moved substantially or traded heavily Wednesday: Juno Therapeutics Inc., up $23.65 to $69.25 The Wall Street Journal reported that biotech drugmaker Celgene may buy the cancer therapy company. ...
Shares of Ford (F) are falling on Wednesday afternoon, after the company issued disappointing guidance late Tuesday. Ford said that it plans to make big investments in autonomous and electric vehicles, not surprising given similar plans by rivals including General Motors (GM) and Tesla (TSLA). Yet investors were more concerned about Ford's bottom line: The automaker expects 2017 earnings to come in at an adjusted $1.78 a share, lower than the $1.84 a share analysts were expecting, while it projected 2018 earnings of $1.45 to $1.70 a share, compared to the $1.59 a share consensus. Not everyone was down on the news, however. Morgan Stanley's Adam Jonas and his team called Ford's warning a "step in the right direction." That said, they reiterated an Underweight rating and $10 price target on the stock, so they're not impressed enough to get more constructive on the stock: Jonas writes that there's no "catharsis" yet despite today's news, and that Ford is in an "amorphous" stage with little transparency into big upcoming projects, and its tax rate won't change much despite the passage of the tax bill.
General Motors (GM) anticipates 2018 earnings to almost match the estimated 2017 results, driven by its array of new product line-ups comprising next-generation trucks.